Page 42 - 2022-12-中国全科医学

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·1447·

［7］STERNE J A C，SAVOVIC J，PAGE M J，et al. RoB 2：a revised Enterobacteriaceae carriage in patients admitted to intensive care unit
tool for assessing risk of bias in randomised trials［J］. BMJ， in a tertiary care hospital in Thailand［J］. Microb Drug Resist，
2019，366：l4898. DOI：10.1136/bmj.l4898. 2019，25（8）：1182-1190. DOI：10.1089/mdr.2018.0318.
［8］卫生部办公厅关于印发《多重耐药菌医院感染预防与控制技术 ［19］KIM S Y，JUNG J Y，KANG Y A，et al. Risk factors for
指南（试行）》的通知［J］. 中华人民共和国国家卫生与计划 occurrence and 30-day mortality for carbapenem-resistant
生育委员会公报，2011，9（2）：59-61. Acinetobacter baumannii bacteremia in an intensive care
［9］李洋，何文英，王忠 . 基于 Meta 分析腹腔镜胆囊切除术中转开 unit［J］. J Korean Med Sci，2012，27（8）：939-947. DOI：
腹风险预测模型的构建［J］. 中国全科医学，2018，21（23）： 10.3346/jkms.2012.27.8.939.
2849-2855. DOI：10.3969/j.issn.1007-9572.2018.00.127. ［20］KOFTERIDIS D P，VALACHIS A，DIMOPOULOU D，et al. Risk
LI Y，HE W Y，WANG Z. Establishment of a risk prediction model factors for carbapenem-resistant Klebsiella pneumoniae infection/
of conversion to open surgery in laparoscopic cholecystectomy based colonization：a case-case-control study［J］. J Infect Chemother，
on a meta-analysis［J］. Chin Gen Pract，2018，21（23）： 2014，20（5）：293-297. DOI：10.1016/j.jiac.2013.11.007.
2849-2855. DOI：10.3969/j.issn.1007-9572.2018.00.127. ［21］MARCHENAY P，BLASCO G，NAVELLOU J C，et al.
［10］AMBERPET R，SISTLA S，PARIJA S C，et al. Screening Acquisition of carbapenem-resistant Gram-negative bacilli in
for intestinal colonization with vancomycin resistant enterococci intensive care unit：predictors and molecular epidemiology［J］.
and associated risk factors among patients admitted to an Med Mal Infect，2015，45（1/2）：34-40. DOI：10.1016/j.
adult intensive care unit of a large teaching hospital［J］. medmal.2014.12.003.
J Clin Diagn Res，2016，10（9）：DC06-09. DOI： ［22］MASSE J，ELKALIOUBIE A，BLAZEJEWSKI C，et al.
10.7860/JCDR/2016/20562.8418. Colonization pressure as a risk factor of ICU-acquired multidrug
［11］BATISTÃO D W，GONTIJO-FILHO P P，CONCEIÇÃO N，et al. resistant bacteria：a prospective observational study［J］. Eur
Risk factors for vancomycin-resistant enterococci colonisation in J Clin Microbiol Infect Dis，2017，36（5）：797-805. DOI：
critically ill patients［J］. Mem Inst Oswaldo Cruz，2012，107（1）： 10.1007/s10096-016-2863-x.
57-63. DOI：10.1590/s0074-02762012000100008. ［23］MCMASTER J，BOOTH M G，SMITH A，et al. Meticillin-
［12］BLANCO N，HARRIS A D，ROCK C，et al. Risk factors and resistant Staphylococcus aureus in the intensive care unit：its effect
outcomes associated with multidrug-resistant Acinetobacter on outcome and risk factors for acquisition［J］. J Hosp Infect，
baumannii upon intensive care unit admission［J］. Antimicrob 2015，90（4）：327-332. DOI：10.1016/j.jhin.2015.04.009.
Agents Chemother，2018，62（1）：e01631-17. DOI：10.1128/ ［24］PAPADIMITRIOU-OLIVGERIS M，MARANGOS M，FLIGOU F，
AAC.01631-17. et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric
［13］COPPRY M，JEANNE-LEROYER C，NOIZE P，et al. Antibiotics colonization upon ICU admission［J］. J Antimicrob Chemother，
associated with acquisition of carbapenem-resistant Pseudomonas 2012，67（12）：2976-2981. DOI：10.1093/jac/dks316.
aeruginosa in ICUs：a multicentre nested case-case-control ［25］REPESSÉ X，ARTIGUENAVE M，PAKTORIS-PAPINE S，
study［J］. J Antimicrob Chemother，2019，74（2）：503-510. et al. Epidemiology of extended-spectrum beta-lactamase-
DOI：10.1093/jac/dky427. producing Enterobacteriaceae in an intensive care unit with no single
［14］DANTAS L F，DALMAS B，ANDRADE R M，et al. Predicting rooms［J］. Ann Intensive Care，2017，7（1）：73. DOI：
acquisition of carbapenem-resistant Gram-negative pathogens in 10.1186/s13613-017-0295-0.
intensive care units［J］. J Hosp Infect，2019，103（2）：121- ［26］ROUTSI C，PRATIKAKI M，PLATSOUKA E，et al. Risk factors
127. DOI：10.1016/j.jhin.2019.04.013. for carbapenem-resistant Gram-negative bacteremia in intensive
［15］HETEM D J，DERDE L P，EMPEL J，et al. Molecular care unit patients［J］. Intensive Care Med，2013，39（7）：
epidemiology of MRSA in 13 ICUs from eight European 1253-1261. DOI：10.1007/s00134-013-2914-z.
countries［J］. J Antimicrob Chemother，2016，71（1）：45- ［27］RUIZ J，GORDON M，VILLARREAL E，et al. Influence of
52. DOI：10.1093/jac/dkv298. antibiotic pressure on multi-drug resistant Klebsiella pneumoniae
［16］KANG J S，YI J，KO M K，et al. Prevalence and risk factors colonisation in critically ill patients［J］. Antimicrob Resist Infect
of carbapenem-resistant Enterobacteriaceae acquisition in an Control，2019，8：38. DOI：10.1186/s13756-019-0484-8.
emergency intensive care unit in a tertiary hospital in Korea：a ［28］SALOMÃO M C，FREIRE M P，BOSZCZOWSKI I，et al.
case-control study［J］. J Korean Med Sci，2019，34（18）： Increased risk for carbapenem-resistant Enterobacteriaceae
e140. DOI：10.3346/jkms.2019.34.e140. colonization in intensive care units after hospitalization in emergency
［17］KAO K C，CHEN C B，HU H C，et al. Risk factors of methicillin- department［J］. Emerg Infect Dis，2020，26（6）：1156-1163.
resistant Staphylococcus aureus infection and correlation with nasal DOI：10.3201/eid2606.190965.
colonization based on molecular genotyping in medical intensive care ［29］SONG J Y，JEONG I S. Development of a risk prediction model
units：a prospective observational study［J］. Medicine （Baltimore）， of carbapenem-resistant Enterobacteriaceae colonization among
2015，94（28）：e1100. DOI：10.1097/MD.0000000000001100. patients in intensive care units［J］. Am J Infect Control，2018，
［18］KIDDEE A，ASSAWATHEPTAWEE K，NA-UDOM A，et 46（11）：1240-1244. DOI：10.1016/j.ajic.2018.05.001.
al. Risk factors for extended-spectrum β-lactamase-producing ［30］VANDRESEN D，WERLANG M H B，SILVA M C B，et al.